The largest database of trusted experimental protocols

Aperio digital at2 pathology system

Manufactured by Leica
Sourced in Australia

The Aperio™ Digital AT2 Pathology System is a digital slide scanner produced by Leica Biosystems. It is designed to digitize glass microscope slides for use in pathology workflows. The system captures high-resolution digital images of tissue samples, which can be viewed and analyzed on a computer.

Automatically generated - may contain errors

2 protocols using aperio digital at2 pathology system

1

Multiparametric IHC of Tumor-Infiltrating T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin-fixed paraffin-embedded tumour tissue was sliced into 4 μm full face sections and processed for 3′,3′-diaminobenzidine (DAB) immunohistochemistry using a Ventana Discovery Ultra (Roche, USA) by the HCB. Sections were labelled for T cell markers CD3 (2GV6; Roche), CD4 (SP35; Roche), CD8 (SP57; Roche), and PD-1 (NAT105; Sigma-Aldrich, USA). All steps from baking to chromogen addition were performed automatically by the instrument. Tissue sections were baked to slides and deparaffinized, and antigen retrieval then occurred at 95°C/pH 9 with a total incubation time of 24 minutes prior to the addition of the primary antibody. Addition of the primary antibody was followed by a 32-minute incubation at 36°C. For CD4 labelling only, the primary antibody was dispensed before the blocking step, resulting in a reduction of non-specific labelling in the tumour tissue. Slides were then incubated with secondary antibody – Anti-Rabbit HQ for CD3, CD4 and CD8, and Anti-Mouse HQ (Roche) for PD-1 – for 20 minutes at 36°C. Positive control (normal tonsil) and negative control (normal brain) tissues were included in each batch of slides to confirm the specificity of antibody labelling (Supplementary Figure 2). Slides were digitally scanned using the Aperio Digital AT2 Pathology System (Leica Biosystems, Australia) for analysis.
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of Metastatic Melanoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
FFPE biopsies for 4 participants (001, 006, 008, 010) collected at baseline, week 9 and week 22 were confirmed to contain metastatic melanoma using H&E stained sections by a pathologist (REV), with the exception of 001 Week 9 biopsy which did not contain viable melanoma. FFPE tumour biopsies were sliced into 4 μm sections and processed for 3′,3′-diaminobenzidine (DAB) immunohistochemistry using a Ventana Discovery Ultra (Roche, USA) by the Hunter Cancer Biobank. Sections were labelled for HLA-A using recombinant Anti-HLA-A antibody (EP1395Y) (AbCam, USA). All steps from baking to chromogen addition were performed automatically by the Ventana Discovery Ultra. Tissue sections were baked to slides and deparaffinized, and antigen retrieval then occurred at 95°C/pH 9 with a total incubation time of 24 minutes prior to the addition of the primary antibody. Addition of the primary antibody was followed by a 32-minute incubation at 36°C. Slides were then incubated with secondary antibody Anti-Rabbit HQ (Roche) for 20 minutes at 36°C. Slides were digitally scanned using the Aperio™ Digital AT2 Pathology System (Leica Biosystems, Australia) for analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!